title: Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential.
authors.affiliation: Division of Cardiac Surgery, Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Shafie S
authors.initials: SS
authors.lastname: Fazel
authors.forename: Denis
authors.initials: D
authors.lastname: Angoulvant
authors.forename: Jagdish
authors.initials: J
authors.lastname: Butany
authors.forename: Richard D
authors.initials: RD
authors.lastname: Weisel
authors.forename: Ren-Ke
authors.initials: RK
authors.lastname: Li
mesh_terms: D000818:Animals; D002471:Cell Transformation, Neoplastic; D006338:Heart Neoplasms / Q000209:etiology*; D045164:Mesenchymal Stem Cell Transplantation / Q000009:adverse effects*; D051379:Mice; D009203:Myocardial Infarction / Q000628:therapy; D019089:Stem Cell Factor / Q000032:analysis*
chemical_list: D019089:Stem Cell Factor